← Stocks · REVB record
Signal record & history · Trifecta Signals
Revelation has been flagged by the Trifecta screener 1 time since 2024. 1 signal confirmed; the median confirmed signal is down 99.3% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Feb 2024 · Latest Feb 2024 · Confirmed 1 of 1 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since February 2024, Revelation has had one Early signal, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for REVB and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Revelation Biosciences sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Its market value of about $2.5 million places it in the small-cap group.
The strongest run on Revelation Biosciences’ record followed a confirmation in February 2024, falling about 33% over the following 90 days. Classification adds texture: it sat in the mid-cap group when that signal fired.
REVB closed Wednesday, November 4 at $4.12, down 7.0% on the day. The last five sessions span about $3.75 to about $4.43.
